Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2008

01-02-2008 | Clinical Study

Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy

Authors: Ou Huang, Liping Wang, Kunwei Shen, Hong Lin, Zhen Hu, Guangyu Liu, Jiong Wu, Jinsong Lu, Zhiming Shao, Qixia Han, Zhenzhou Shen

Published in: Breast Cancer Research and Treatment | Issue 3/2008

Login to get access

Abstract

Purpose

The selective treatment of internal mammary lymph nodes (IMNs) in breast cancer is controversial. The purpose of this research was to determine the subpopulation patients with high risk of internal mammary lymph nodes metastasis who received extended radical mastectomy without any preoperative treatment from 1956 to 2003 in China.

Patients and methods

1,679 Chinese patients were underwent extended radical mastectomy (ERM) between 1956 and 2003. Four individual variables were selected (tumor site, tumor size, the number of ALNs involvement, patient age),then classified by following standards: tumor site(lateral, central, medial),tumor size(T1:≤2 cm; T2:2 < T ≤ 5 cm, T3:>5 cm), ALNs(0,1–3,4–6, ≥7), age(≤35 y, 36–50 y, >50 y). Chi-square and binary logistic regression were used to analysis relationship of these variable and IMMs.

Results

The four individual variables were significantly associated with IMNs metastasis using univariate analysis. However, three individual variables except for tumor size independently impact the IMNs metastasis using multivariate analysis. The incidence of IMNs metastasis in patients with 4–6 and ≥7 positive ALNs was 28.1%, 41.5%. Within subgroup patients with medial tumor and positive ALNs, the incidence of IMNs metastasis was 23.6% for patients with 1–3 positive ALNs, and 47.5% for 4–6 positive ALNs, 38.7% for patients with ≥7 positive ALNs. The incidence of IMNs metastasis was 25.4% for patients with T3 tumor and younger than 35 y.

Conclusion

Patients with following conditions had high risk of IMNS metastasis: (1) patients with 4 or more positive ALNs. (2) patients with medial tumor and positive ALNs.(3) patients with T3 tumor and younger than 35 y. (4) patients with T2 tumor and positive ALNs.(5) patients with T2 tumor and medial tumor .The incidences of IMNS metastasis for those patients were more than 20%.
Appendix
Available only for authorised users
Literature
1.
go back to reference Handley R (1996) Natural history of breast cancer. In: Harris J, Lippman ME, Morrow M et al (eds) Diseases of the Breast. WB Saunders, Philadelphia, PA, p 384 Handley R (1996) Natural history of breast cancer. In: Harris J, Lippman ME, Morrow M et al (eds) Diseases of the Breast. WB Saunders, Philadelphia, PA, p 384
2.
go back to reference Veronesi U, Marubini E, Mariani L et al (1999) The dissection of internal mammary nodes does not improve the survival of breast cancer patients: 30-year results of a randomized trial. Eur J Cancer 35:1320–1325PubMedCrossRef Veronesi U, Marubini E, Mariani L et al (1999) The dissection of internal mammary nodes does not improve the survival of breast cancer patients: 30-year results of a randomized trial. Eur J Cancer 35:1320–1325PubMedCrossRef
3.
go back to reference Singletary SE, Allred C, Ashley P et al (2002) Revision of the American Joint Committee on Cancer Staging System for Breast Cancer. J Clin Oncol 20:3628–36PubMedCrossRef Singletary SE, Allred C, Ashley P et al (2002) Revision of the American Joint Committee on Cancer Staging System for Breast Cancer. J Clin Oncol 20:3628–36PubMedCrossRef
4.
go back to reference Veronesi U, Cascinelli N, Greco M et al (1985) Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 202:702–707PubMedCrossRef Veronesi U, Cascinelli N, Greco M et al (1985) Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 202:702–707PubMedCrossRef
5.
go back to reference Li KYY, Shen Z-Z (1984) An analysis of 1242 cases of extended radical mastectomy. Breast: Dis Breast 10:10–19 Li KYY, Shen Z-Z (1984) An analysis of 1242 cases of extended radical mastectomy. Breast: Dis Breast 10:10–19
6.
go back to reference Gaffney DK, Tsodikov A, Wiggins CL (2003) Diminished survival in patients with inner versus outer quadrant breast cancers. J Clin Oncol 21:467–472PubMedCrossRef Gaffney DK, Tsodikov A, Wiggins CL (2003) Diminished survival in patients with inner versus outer quadrant breast cancers. J Clin Oncol 21:467–472PubMedCrossRef
7.
go back to reference Lacour J, Bucalossi P, Cacers E et al (1976) Radical mastectomy versus radical mastectomy plus internal mammary dissection: Five year results of an international cooperative study. Cancer 37:206–214PubMedCrossRef Lacour J, Bucalossi P, Cacers E et al (1976) Radical mastectomy versus radical mastectomy plus internal mammary dissection: Five year results of an international cooperative study. Cancer 37:206–214PubMedCrossRef
8.
go back to reference Hojris I, Overgaard M, Christensen JJ, Overgaard J (1999) Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: Analysis of DBCG 82b and 82c randomised trials. Lancet 354(9188):1425–1430PubMedCrossRef Hojris I, Overgaard M, Christensen JJ, Overgaard J (1999) Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: Analysis of DBCG 82b and 82c randomised trials. Lancet 354(9188):1425–1430PubMedCrossRef
9.
go back to reference Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen MB, Zedeler K, Andersson M (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337(14):949–955PubMedCrossRef Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen MB, Zedeler K, Andersson M (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337(14):949–955PubMedCrossRef
Metadata
Title
Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy
Authors
Ou Huang
Liping Wang
Kunwei Shen
Hong Lin
Zhen Hu
Guangyu Liu
Jiong Wu
Jinsong Lu
Zhiming Shao
Qixia Han
Zhenzhou Shen
Publication date
01-02-2008
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2008
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-007-9561-4

Other articles of this Issue 3/2008

Breast Cancer Research and Treatment 3/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine